# Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer

> **NCT07014618** · — · RECRUITING · sponsor: **University of Oklahoma** · enrollment: 420 (estimated)

## Conditions studied

- Breast Cancer
- Prostate Cancer

## Interventions

- **OTHER:** Pre & Post Surveys
- **OTHER:** Opt Out of Questionnaire

## Key facts

- **NCT ID:** NCT07014618
- **Lead sponsor:** University of Oklahoma
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2025-10-16
- **Primary completion:** 2029-10
- **Final completion:** 2030-10
- **Target enrollment:** 420 (ESTIMATED)
- **Last updated:** 2025-12-17

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07014618

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07014618, "Navigator-Assisted Hypofractionation (NAVAH) on Radiation Therapy Completion in Breast Cancer and Prostate Cancer". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07014618. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*